Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FKEMY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $90,246
Award facts
- Contract value 100% obligated
- $90,245.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $90,245.65 by the Defense Logistics Agency (DLA) on September 26, 2025. The delivery order, which carries an ultimate completion date of October 20, 2025, is for Keytruda 100 mg/4 ml vials—a branded immunotherapy medication used in oncology treatments. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on the open market despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, known as the SPE2DB program. Through this comprehensive pharmaceutical supply vehicle, the DLA leverages DMS Pharmaceutical Group's capabilities to procure a broad range of prescription medications, biologics, and medical consumables to support military health facilities worldwide. The company's established role as a critical supplier in the federal pharmaceutical supply chain positions it to fulfill the specialized oncology medication requirements of Department of Defense healthcare systems on an as-needed basis.
Quick answers
Who was awarded contract SPE2DB25FKEMY?
SPE2DB25FKEMY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FKEMY worth?
The government has obligated $90,246 on SPE2DB25FKEMY.
Is contract SPE2DB25FKEMY an order under another contract?
Yes. SPE2DB25FKEMY is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEMY competed?
The extent of competition for SPE2DB25FKEMY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award